• 1-myristoylglycerophosphocholine: Unraveling Lipid Signaling

  2026-07-08

  Discover how 1-myristoylglycerophosphocholine empowers novel lipid signaling pathway analysis in fibrosis research. This article uniquely integrates mechanistic insights with assay optimization, bridging recent breakthroughs to practical experimental strategies.

• D-N-Acetylgalactosamine: Technical Use in Glycoprotein Analy

  2026-07-07

  D-N-Acetylgalactosamine is a high-purity, water-soluble metabolite essential for rigorous analysis of glycoprotein constituents, especially in neurological and brain heteropolysaccharide research. It is not compatible with workflows requiring ethanol solubility or long-term storage of solutions, and precise handling is required to ensure data quality.

• Syringin Enhances Sunitinib Sensitivity via EGFR/PI3K/Akt in

  2026-07-07

  This study identifies syringin as a promising adjunct to Sunitinib therapy in renal cell carcinoma (RCC) by demonstrating its ability to inhibit cell proliferation, promote apoptosis, and reduce resistance through EGFR/PI3K/Akt pathway modulation. The findings highlight a potential strategy to overcome Sunitinib resistance and improve therapeutic outcomes in RCC models.

• Nuclear Condensate Assembly by Drosophila Keap1 Under Oxidat

  2026-07-06

  This study uncovers how the Drosophila Keap1 protein forms nuclear condensates in response to oxidative stress, revealing a new aspect of Keap1-Nrf2 pathway regulation. The discovery advances our understanding of oxidative stress responses and highlights the mechanistic role of intrinsically disordered regions in nuclear condensate formation.

• GSK126: Precision EZH2 Inhibition Redefining Cancer Epigenet

  2026-07-06

  This article provides translational researchers with a mechanistic and strategic exploration of GSK126, a potent EZH2 inhibitor, highlighting its impact on epigenetic regulation in oncology and immune modulation. Bridging recent mechanistic insights—such as the Ezh2/p53 competition for lncRNA Neat1 transcription and inflammasome activation—with practical protocol guidance, it positions GSK126 (APExBIO) as a transformative tool in cancer epigenetics research and oncology drug development.

• LncRNA MRF Regulates BMSC Osteogenesis via cAMP-PKA-CREB Pat

  2026-07-05

  This study by Ning et al. identifies lncRNA MRF as a negative regulator of osteogenic differentiation in bone marrow mesenchymal stem cells (BMSCs), acting through the cAMP-PKA-CREB signaling pathway by targeting FSHR. The findings provide novel mechanistic insights into gene expression regulation in bone formation and highlight potential therapeutic targets for bone disorders.

• Reactive Oxygen Species Assay Kit: Applied Workflows & Insig

  2026-07-04

  The APExBIO Reactive Oxygen Species (ROS) Assay Kit (DHE) delivers precise, quantitative intracellular superoxide detection for advanced redox and apoptosis research. Discover optimized experimental workflows, troubleshooting strategies, and translational applications that set this kit apart in oxidative stress and immunomodulation studies.

• Multiplexed ACE2 Profiling Reveals SARS-CoV-2 Variant Adapta

  2026-07-03

  This study introduces a high-throughput platform to assess how SARS-CoV-2 spike protein variants interact with diverse ACE2 receptor sequences. The findings map variant-specific shifts in receptor compatibility and provide a framework to investigate viral adaptation and cross-species transmission.

• Chronic E-64 Cathepsin Inhibition in Salt-Sensitive Hyperten

  2026-07-03

  This study systematically investigates whether chronic inhibition of cysteine cathepsins with E-64 alters the development of salt-sensitive hypertension and renal injury in Dahl rats. Contrary to expectations, E-64 had no significant effect on blood pressure or kidney damage, providing important clarification for researchers evaluating cysteine protease inhibition in cardiovascular and renal models.

• Oleic Acid (C18:1(9Z)): Optimizing Lipid Metabolism Research

  2026-07-02

  This article addresses common experimental challenges in lipid metabolism and cell viability workflows, demonstrating how Oleic Acid (SKU C4977) from APExBIO provides reliable, reproducible solutions. Using scenario-driven Q&A blocks, it synthesizes evidence-based recommendations for assay optimization and data interpretation with Oleic Acid.

• Sinapine Disrupts Gαq-PLCβ3 Axis to Ameliorate Cardiovascula

  2026-07-02

  This study uncovers how sinapine targets the EF hands domain of PLCβ3, selectively disrupting the Gαq-PLCβ3 interaction and thereby ameliorating aldosteronism and hypertension in animal models. The work highlights a mechanistically precise approach to modulating calcium signaling in cardiovascular disease, addressing key limitations of previous pan-PLC and Gαq inhibitors.

• EPA Omega-3: Mechanistic Leverage for Translational Success

  2026-07-01

  Translational researchers face a strategic inflection point: how to rationally select and implement lipid mediators like Eicosapentaenoic Acid (EPA) for maximum impact in cardiovascular and immunometabolic research. This article delivers a thought-leadership perspective blending state-of-the-art mechanistic findings, experimental guidance, and cross-domain insights—anchored by APExBIO’s high-purity EPA and the latest evidence on prostaglandin modulation and immune response. By connecting the dots across endothelial biology, lipid oxidation, and emerging immunological paradigms, we chart the path toward robust, reproducible results and next-generation applications.

• SmD2 Acetylation Regulates PARP Inhibitor Sensitivity in HCC

  2026-07-01

  This study uncovers how acetylation of the spliceosome core protein SmD2 modulates alternative exon usage and DNA repair in hepatocellular carcinoma (HCC), directly affecting cellular sensitivity to PARP inhibitors. These mechanistic insights suggest new therapeutic avenues for targeting DNA repair vulnerabilities in BRCA-proficient HCC.

• Substance P in Pain Transmission Research: Applied Protocols

  2026-06-30

  Unlock the full potential of the tachykinin neuropeptide Substance P in CNS and immune response studies with high-purity solutions and advanced spectral analysis. This guide details actionable workflows, troubleshooting tips, and recent breakthroughs that eliminate environmental interference, driving more robust neuroinflammation and pain research.

• Optimizing ARCA Capped mRNA Synthesis with HyperScribe Kit

  2026-06-30

  The HyperScribe All in One mRNA Synthesis Kit Plus 1 streamlines ARCA-capped, immune-evasive mRNA workflows for vaccine development and functional genomics. Discover how this APExBIO kit enables robust, high-yield synthesis with unique protocol enhancements, real-world troubleshooting, and direct guidance from recent animal model breakthroughs.

8198 records 8/547 page Previous Next First page 上5页 678910 下5页 Last page